Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

SfN 2015 Recap: Harnessing the Power of Microglia in Neurodegenerative Diseases

November 6, 2015 8:49 am | by Stephanie Guzowski, Editor | Articles | Comments

Microglia, which comprise 10 to 15 percent of all cells found within the brain, act as the primary defenders in the central nervous system (CNS). But scientists are finding out that these immune cells play a significant role in shaping neural circuits, and may be implicated in developmental and neurodegenerative disorders. Read more...


New Research Could Help Fight in the Fight Against Infection, Cancer, and Allergies

November 6, 2015 8:15 am | by University of Southampton | News | Comments

Their research has explored the pliability of the protein and how its ability to shape-shift dictates its function. Read more...


Immunologists Unearth Key Piece of MRSA Vaccine Puzzle

November 6, 2015 8:00 am | by Trinity College Dublin | News | Comments

To date, around eight promising candidate vaccines have failed in clinical trials, despite showing promise in pre-clinical models. Read more...


Novel Method Predicts Adverse Drug Reactions

November 6, 2015 7:45 am | by IMIM | News | Comments

In Europe, nearly 200,000 people die every year from adverse drug reactions, seven times more than in traffic accidents. Read more...


One Step Closer to Finding an Effective HIV Vaccine

November 6, 2015 7:30 am | by University of Melbourne | News | Comments

Approximately 34 million people have died due to HIV-related causes worldwide. Read more...


GSK Gets FDA Approval for Add-on Treatment for Asthma

November 6, 2015 7:15 am | News | Comments

This is the first marketing authorization granted for mepolizumab anywhere in the world. Read more...


Tapeworm Cancer Spreads to Human Hosts

November 6, 2015 7:00 am | by Seth Augenstein, Digital Reporter | News | Comments

The new observation came from strange biopsies in a patient in Colombia two years ago. Read more...


FDA Grants Fast Track Designation for Long-acting Buprenorphine Injections to Treat Opioid Addiction

November 5, 2015 11:10 am | News | Comments

Braeburn Pharmaceuticals and Camurus announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for the CAM2038 weekly and monthly buprenorphine subcutaneous injection products under development for the treatment of opioid addiction. Read more...


Biologics for Asthma: Attacking the Source of the Disease, Not the Symptoms

November 5, 2015 11:06 am | by American College of Allergy, Asthma, and Immunology | News | Comments

Imagine you suffer from severe asthma, and you've tried every treatment available, but nothing has worked. You still can't breathe. Then a new therapy comes along that attacks the source of the asthma, as opposed to the symptoms, and treats the disease at a cellular level. Read more...


Heroin, Prescription Pain Pills Top Drug Threat in the U.S.

November 5, 2015 11:03 am | by Alicia A. Caldwell, Associated Press | News | Comments

Heroin and prescription pain pills are among the top drug threats in the U.S., according to the Drug Enforcement Administration's latest drug threat assessment Wednesday. Read more...


Pfizer Doubling Patient Income Limit for Free Drug Program

November 5, 2015 11:01 am | by Linda A. Johnson, AP Business Writer | News | Comments

Pfizer, the biggest U.S.-based drugmaker, is increasing its financial assistance to patients, doubling the allowable income level for people to receive dozens of Pfizer medicines for free. Read more...


SfN 2015 Recap: The Role of Synapses, Neural Networks in Alzheimer’s

November 5, 2015 10:15 am | by Stephanie Guzowski, Editor | Articles | Comments

Cognition and behavior rely on communication between individual neurons and extensive interactions between neural networks. But when synaptic dysfunction occurs, the results can be dire, leading to neurodegenerative symptoms in Alzheimer’s disease. “Our ability to treat these diseases is limited at the moment. We need new insight into what goes wrong,” said Valina Dawson, Ph.D., of Johns Hopkins University. Read more...


Bi-monthly Injections Suppress HIV Instead of Daily Drugs

November 5, 2015 9:41 am | by Seth Augenstein, Digital Reporter | News | Comments

HIV patients have to take a constant, unremitting succession of daily drugs to keep the virus in check. But a new combination of bi-monthly injections can do the same work to suppress the disease, according to a new announcement by Johnson and Johnson and GlaxoSmithKline. Read more...


Heat-Activated 'Grenade' to Target Cancer

November 5, 2015 8:15 am | by University of Manchester | News | Comments

Two new studies show the team has taken a step closer to solving this problem by fitting liposomes with a heat-activated trigger. Read more...


Opioid Overdoses Linked to Higher Prescription Rates in British Columbia

November 5, 2015 8:00 am | by University of British Columbia | News | Comments

UBC researchers collected data about the amount of opioids prescribed across 79 of the local health areas of B.C from 2004 to 2013. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.